The infant microbiome and implications for central nervous system development

E Parsons, K Claud, EO Petrof - Progress in Molecular Biology and …, 2020 - Elsevier
Neurodevelopmental impairment remains a significant morbidity in former very low birth
weight premature infants. There is increasing evidence the microbiome affects …

Multiplex phenotyping for systems medicine: a one-point optimized practical sampling strategy for simultaneous estimation of CYP1A2, CYP2C9, CYP2C19, and …

F de Andrés, S Terán, M Bovera, H Farinas… - OMICS: A Journal of …, 2016 - liebertpub.com
Phenotyping of the CYP450 enzyme activities contributes to personalized medicine, but the
past phenotyping approaches have followed a piecemeal strategy measuring single enzyme …

Limited sampling strategy for the prediction of area under the curve (AUC) of statins: reliability of a single time point for AUC prediction for pravastatin and simvastatin

NR Srinivas - Drug Research, 2016 - thieme-connect.com
Statins are widely prescribed medicines and are also available in fixed dose combinations
with other drugs to treat several chronic ailments. Given the safety issues associated with …

[图书][B] Applying pharmacogenomics in therapeutics

X Feng, HG Xie - 2016 - books.google.com
Recent advances in high-throughput gene sequencing and other omics biotechnologies
have served as a springboard for the field of pharmacogenomics. Pharmacogenomics is …

A framework and case studies for evaluation of enzyme ontogeny in children's health risk evaluation

G Ginsberg, SV Vulimiri, YS Lin… - Journal of Toxicology …, 2017 - Taylor & Francis
Knowledge of the ontogeny of Phase I and Phase II metabolizing enzymes may be used to
inform children's vulnerability based upon likely differences in internal dose from xenobiotic …

[HTML][HTML] Effects of vercirnon on the activity of CYP3A4, CYP2C19 and CYP2C8 enzymes and BCRP and OATP1B1 transporters using probe substrates

LJ Haberer, I McSherry, A Cargill… - European journal of clinical …, 2014 - Springer
Purpose Vercirnon is a CCR9 chemokine receptor antagonist being developed for the
treatment of Crohn's disease. As a variety of concomitant medications are often required for …

Evaluation of omeprazole limited sampling strategies to estimate constitutive cytochrome P450 2C19 activity in healthy adults

S Lin, M Nikanjam, EV Capparelli… - Therapeutic drug …, 2018 - journals.lww.com
Background: Limited sampling strategy (LSS) is a validated method to estimate
pharmacokinetic (PK) parameters from a reduced number of samples. Omeprazole is used …

1 Concepts in Pharmacogenomics and Personalized Medicine

KC Lee, JD Ma, GM Kuo - Applying Pharmacogenomics in …, 2016 - books.google.com
Pharmacogenomics is a rapidly expanding field that will have a significant impact on patient
care and the role of healthcare professionals in providing personalized care. The clinical …